Characterization of Gastric Cancer (Stomach Cancer) its Situation and Nanotech/Nanoemulsion Treatment: Schematic Overview
Your stomach's inner lining is typically where cancer cells start when you have stomach cancer, also known as gastric cancer. As the cancer progresses, it infiltrates your stomach walls more deeply. Early accounts of potential stomach cancer were documented in the Ebers papyrus, which dates back to 1600 BC, and in the Hippocrates reports, which Galen related from Rome in the second century AD. According to legend, Hippocrates was the 18th successor of Aesculapius as Master of the Greek Medical School. He lived in Greece in the fourth century BC, between Kos and Athens. He was the first to use the terms "cancer" and "carcinoma" (Karkinos and Karkinoma in Greek), but he thought that this disease entered the body through the skin and spread to soft tissues and interior organs. Because corpses could not be used for medical anatomical investigations in Egyptian, Greek, or Roman cultures, Hippocrates had firsthand experience with only exterior cancers. According to GLOBOCAN 2022 data, GI cancers accounted for 24.6% of all new cancer cases globally, causing over one-third (34.2%) of all deaths and imposing a significant cost on human health. The location and stage of stomach cancer determine the available treatment choices. When creating a treatment plan, your healthcare professional also considers your preferences and general health. Treatments for stomach cancer include immunotherapy, targeted therapy, radiation therapy, chemotherapy, surgery, and palliative care. Pharmaceutical formulations made up of particles of a nanometer range are called nanoemulsions. Because of their hydrophobic core, they can encapsulate medications that are not very soluble in water. They are a steady and secure alternative for drug delivery because they are also made of safe gradient excipients. The topic of cancer treatment has existed for several decades. Low solubility, multidrug resistance (MDR), and unspecific toxicity are the main reasons why medications created to treat this illness don't always work or fail. It may be possible to treat tumours safely and effectively with nanoemulsions. We evaluate the current status of stomach cancer, potential treatments, and underlying causes in this article.
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2024-12-25
- DOI
- https://doi.org/10.5281/zenodo.14555856
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00